Gara Jalqabaatti › Schizophrenia
Qorannoo klinikaalii Schizophrenia Ameerikaa Keessatti hirmaatuu
Qorannoo 106 Schizophrenia f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Atlanta, GAQorannoo 22
- Chicago, ILQorannoo 21
- Little Rock, ARQorannoo 19
- Hollywood, FLQorannoo 15
- Boston, MAQorannoo 14
- Houston, TXQorannoo 13
- Hialeah, FLQorannoo 13
- Austin, TXQorannoo 13
- San Diego, CAQorannoo 13
- New York City, NYQorannoo 13
- Garden Grove, CAQorannoo 12
- Germantown, MDQorannoo 11
- Miami, FLQorannoo 10
- Camden, NJQorannoo 10
- Richardson, TXQorannoo 9
- Philadelphia, PAQorannoo 8
- Anaheim, CAQorannoo 8
- Cincinnati, OHQorannoo 8
- Dallas, TXQorannoo 8
- Johns Creek, GAQorannoo 8
- St. Louis, MOQorannoo 8
- Grand Prairie, TXQorannoo 8
- Inglewood, CAQorannoo 8
- El Cajon, CAQorannoo 8
- Los Angeles, CAQorannoo 8
- Cambridge, MAQorannoo 8
- Las Vegas, NVQorannoo 7
- Springdale, ARQorannoo 7
- West Palm Beach, FLQorannoo 7
- Pittsburgh, PAQorannoo 7
- Orange, CAQorannoo 7
- Staten Island, NYQorannoo 7
- Oceanside, CAQorannoo 6
- Richmond, VAQorannoo 6
- Nashville, TNQorannoo 6
- Orlando, FLQorannoo 6
- Chino, CAQorannoo 6
- Akron, OHQorannoo 6
- Riverside, CAQorannoo 6
- Torrance, CAQorannoo 6
Naannoon
- AlabamaQorannoo 5
- ArizonaQorannoo 4
- ArkansasQorannoo 21
- CaliforniaQorannoo 45
- ColoradoQorannoo 3
- ConnecticutQorannoo 9
- FloridaQorannoo 26
- GeorgiaQorannoo 29
- IllinoisQorannoo 26
- MarylandQorannoo 18
- MassachusettsQorannoo 22
- MichiganQorannoo 5
- MinnesotaQorannoo 5
- MississippiQorannoo 3
- MissouriQorannoo 11
- NebraskaQorannoo 6
- NevadaQorannoo 7
- New JerseyQorannoo 13
- New YorkQorannoo 23
- North CarolinaQorannoo 4
- OhioQorannoo 18
- OklahomaQorannoo 4
- PennsylvaniaQorannoo 15
- TennesseeQorannoo 6
- TexasQorannoo 34
- VirginiaQorannoo 6
- WashingtonQorannoo 8
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05491538Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07853807Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05648591iTBS to Enhance Social Cognition in People With Psychosis
Namoota walitti qabaa jira
Umuriin 18 hanga 39 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06118268Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07680114Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07101094Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
Namoota walitti qabaa jira
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06835556A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07686263NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07105098NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07114874Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 5 hanga 17 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06229210Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07227818Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07680946A Study of Brenipatide in Adult Participants With Schizophrenia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07410507State Representation in Early Psychosis 2
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 15 hanga 45 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07834203A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 5 hanga 17 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07424404A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07734493Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
Namoota walitti qabaa jira
Umuriin 22 hanga 65 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT05276050A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT0714591852-week Open Label Safety-Tolerability Study
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 13 hanga 17 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07061288Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 21 hanga 60 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06058702Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.